Product directions
Unbranded packaging concept: Peptide feasibility
AI-generated white-label packaging concept. Final pack and appearance follow sample approval. View 4K upscaled image

Copper Tripeptide-1 serum and dual-chamber OEM feasibility

Custom development review · Peptide feasibility

The public direction uses Copper Tripeptide-1 rather than borrowed brand mechanisms. It is a feasibility route until the exact raw-material dossier and formula stability are approved.

MOQ & quotation
Confirmed for the selected formula, fill size, packaging and order plan.
Samples & production
Timing is confirmed after formula scope, packaging availability and required tests are reviewed.
Your brand
Original label and packaging design, with product wording reviewed for the destination market.

Formula, format & packaging options

Published reference values describe the cited ingredient or study. They are not test results for a FANGKE finished formula. Project options are selections to review in your development brief.

Copper Tripeptide-1 aqueous serum

Low-metal-ion aqueous gel with Copper Tripeptide-1 grade, humectants and a compatible preservation/rheology system.

Product format
Blue aqueous serum, 15–30 mL
Packaging route
15–30 mL opaque or UV-screening airless pump
Copper Tripeptide-1 aqueous serum Specifications
ParameterDevelopment detailBasis
Product formatBlue aqueous serum, 15–30 mLProject option
Pack configuration15–30 mL opaque or UV-screening airless pumpProject option
Development routeSingle-phase peptide serum; project screen pH 5.0–6.5, low chelator load and controlled headspaceProject option
Representative supplier formula1.0% of a multi-component peptide ingredient at final pH 5.0–5.5; Copper Tripeptide-1 active percentage is not disclosedPublished reference[1]

Checks for the selected formula

  • Confirm raw-material active content/carrier by current TDS and COA, then assay or fingerprint the finished batch as appropriate.
  • Track color, pH, peptide compatibility and pack adsorption under light, heat and freeze-thaw conditions.

Destination-market notes

Position as a peptide serum only after dossier and claims review. Do not claim wound healing, tissue regeneration or injectable equivalence.

Dual-chamber Copper Tripeptide-1 + hyaluronate serum

Separate peptide chamber and hyaluronate/humectant chamber when incompatibility or shelf-life evidence justifies separation.

Product format
Two low-viscosity serums mixed at dispensing, total 20–40 mL
Packaging route
1:1 or validated asymmetric dual-chamber airless pack
Dual-chamber Copper Tripeptide-1 + hyaluronate serum Specifications
ParameterDevelopment detailBasis
Product formatTwo low-viscosity serums mixed at dispensing, total 20–40 mLProject option
Pack configuration1:1 or validated asymmetric dual-chamber airless packProject option
Development routeChamber A peptide at pH 5.0–6.5; Chamber B hyaluronate gel; ratio confirmed by pump meteringProject option
Representative supplier formula1.0% of a multi-component peptide ingredient at final pH 5.0–5.5; not a Copper Tripeptide-1 active-dose disclosurePublished reference[1]

Checks for the selected formula

  • Verify chamber isolation, dose ratio, simultaneous priming, mixing uniformity and residual product at end of use.
  • Compare peptide/color stability in dual-chamber and single-phase controls before selecting the higher-complexity pack.

Destination-market notes

Dual chamber is justified by stability or user experience, not by an unsupported activation story. MOQ and component supply depend on the selected pack.

Project questions

Do source-reference values describe a ready Fangke formula?

No. They are traceable supplier, regulatory or research benchmarks. Formula ownership, raw-material grade, dosage, pilot feasibility, MOQ, lead time, claims and destination-market status are confirmed only for the individual project.

Which tests are included before commercialization?

The program is set after the formula, pack, intended use and market are known. Typical work includes specifications, stability, pack compatibility, microbiological quality or preservative efficacy and safety review. SPF, brightening, wrinkle or other performance claims need dedicated substantiation.

Technical references & source scope

These references support ingredient selection, formulation questions and market review. A quoted study, supplier test or regulatory limit does not establish finished-product efficacy or approval.

  1. X50 CellMatrix Booster Serum NDF054 — representative formulation Evonik

    Representative supplier serum uses 1.0% of a multi-component ingredient that includes Copper Tripeptide-1 and is adjusted to pH 5.0–5.5. The document does not disclose the active peptide percentage; it is not a Fangke formula, dosage recommendation or freedom-to-operate opinion.

Content reviewed:

Send a product brief

Include your destination country, quantity, preferred option, fill size and packaging. We will review the formula route and quotation inputs.